COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,696 Articles (22,913 medRxiv, 8,783 bioRxiv)

Most recent first Previous |  Page 1869: Articles 18681-18690  | Next

Insights on SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival
Luan, B., Huynh, T.
10.1101/2021.02.06.430088 — Posted: 2021-02-07
The local topological free energy of the SARS-CoV-2 Spike protein
Baldwin, Q., Sumpter, B. G., Panagiotou, E.
10.1101/2021.02.06.430094 — Posted: 2021-02-07
Targeting CTP Synthetase 1 to Restore Interferon Induction and Impede Nucleotide Synthesis in SARS-CoV-2 Infection
Rao, Y., Wang, T.-Y., Qin, C., Espinosa, B., Liu, Q., Ekanayake, A., Zhao, J., Savas, A. C., Zhang, S., Zarinfar, M., Liu, Y., Zhu, W., Graham, N. A., Jiang, T., Zhang, C., Feng, P.
10.1101/2021.02.05.429959 — Posted: 2021-02-07
Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants.
Liu, Z., Wu, H., Egland, K. A., Gilliland, T. C., Dunn, M. D., Luke, T. C., Sullivan, E. J., Klimstra, W. B., Bausch, C. L., Whelan, S. P. J.
10.1101/2021.02.06.430072 — Posted: 2021-02-07
A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus macaques
Deng, S.-J., cao, X., Gu, C., Wang, Z., Liu, P., Liu, X., Gao, L., Jia, F., Yu, L., Li, N., Jiang, G., Zhang, J., Yang, L., Shi, M., Hou, T., Li, Y., Liang, W., Lu, G., Yang, C., Wang, Y., Xia, K., Xiao, Z., Xue, J., Huang, X., Chen, X., Pan, Z., Wang, X., Guo, H., Liang, H., Yao, Y., Gao, G., Peng, Y., Hu, X., Min, J., Zhou, Y., Liu, K., Guo, W., Yuan, Z., Song, D., Guan, W., Ma, H., Hu, X., Zhang, Y., Chen, Z., Shan, C.
10.1101/2021.02.07.429299 — Posted: 2021-02-07
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies
Tada, T., Dcosta, B. M., Samanovic-Golden, M., Herati, R. S., Cornelius, A., Mulligan, M. J., Landau, N. R.
10.1101/2021.02.05.430003 — Posted: 2021-02-07
Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
Washington, N. L., Gangavarapu, K., Zeller, M., Bolze, A., Cirulli, E. T., Schiabor Barrett, K. M., Larsen, B. B., Anderson, C., White, S., Cassens, T., Jacobs, S., Levan, G., Nguyen, J., Ramirez, J. M., Rivera-Garcia, C., Sandoval, E., Wang, X., Wong, D., Spencer, E., Robles-Sikisaka, R., Kurzban, E., Hughes, L. D., Deng, X., Wang, C., Servellita, V., Valentine, H., De Hoff, P., Seaver, P., Sathe, S., Gietzen, K., Sickler, B., Antico, J., Hoon, K., Liu, J., Harding, A., Bakhtar, O., Basler, T., Austin, B., Isaksson, M., Febbo, P., Becker, D., Laurent, M., McDonald, E., Yeo, G. W., Knight, R., Laurent, L. C., de Feo, E., Worobey, M., Chiu, C., Suchard, M. A., Lu, J. T., Lee, W., Andersen, K. G.
10.1101/2021.02.06.21251159 — Posted: 2021-02-07 Discussion: Offsite
Subgenomic RNAs as molecular indicators of asymptomatic SARS-CoV-2 infection
Wong, C. H., Ngan, C. Y., Goldfeder, R. L., Idol, J., Kuhlberg, C., Maurya, R., Kelly, K., Omerza, G., Renzette, N., Abreu, F. D., Li, L., Browne, F. A., Liu, E. T., Wei, C.-L.
10.1101/2021.02.06.430041 — Posted: 2021-02-06
Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India
Dravid, A., Kashiva, R., Khan, Z., Memon, D., Kodre, A., Potdar, P., Mane, M., Borse, R., Pawar, V., Patil, D., Banerjee, D., Bhoite, K., Pharande, R., Kalyani, S., Raut, P., Bapte, M., Mehta, A., Reddy, M. S., Bhayani, K., Laxmi, S. S., Vishnu, P. D., Srivastava, S., Khandelwal, S., More, S., Shinde, R., Pawar, M., Harshe, A., Kadam, S., Mahajan, U., Joshi, G., Mane, D.
10.1101/2021.02.04.21249959 — Posted: 2021-02-06
Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2
Coyle, P. V., El Kahlout, R. A., Dargham, S. R., Chemaitelly, H., Kacem, M. A. B. H., Al-Mawlawi, N. H. A., Gillani, I., Younes, N., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Jeremijenko, A. M., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Tang, P. M., Bertollini, R., Al-Thani, M. H., Abu-Raddad, L. J.
10.1101/2021.02.04.21251126 — Posted: 2021-02-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).